Vaxil Bio Ltd. (VAXIL BIO LTD) aksje
VXL.V
Stengt$0.23000.0000 (0.00%)
Laster graf...
VAXIL BIO LTD
Market Cap
$916,324
Åpning0.2300
Høy0.2300
Lav0.2300
Volum42
P/E1.28
Markedsverdi916.32k
52-ukers høy0.3250
52-ukers lav0.1300
Gj.sn. volum1.82k
UtbytteN/A
BetaN/A
EPS0.1800
Om Vaxil Bio Ltd. (VAXIL BIO LTD) aksje
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. Its lead product candidate is ImMucin, a MUC1 SP-based vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. The company is headquartered in Toronto, Canada.
Selskapsinformasjon
Børs: TSXV (VAN)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
559 Briar Hill Avenue
M5N 1N1 Toronto, Canada
M5N 1N1 Toronto, Canada
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål